VJHemOnc Podcast

VJHemOnc Podcast

Por: VJHemOnc
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com
200 episodios disponibles

Latest episodes of the podcast VJHemOnc Podcast

Mostrando página 2 de 10

CHIP & CCUS: advances in understanding and should we treat these precursor conditions? 20/06/2025
Diagnosing amyloidosis: identifying early signs, appropriate diagnostic tests, and challenges that remain 14/06/2025
IPIG 2025 Highlights: challenging situations in PNH, updates from the COMMODORE trials, and more 05/06/2025
Recent advances in Hodgkin lymphoma treatment: novel regimens, ongoing trials & treating R/R disease 30/05/2025
Gene therapy in sickle cell disease: patient selection, potential complications, & more 23/05/2025
Highlights from iwCAR-T 2025: improving the efficacy and safety of CAR T-cells & access in the community 19/05/2025
Updates to the ESMO CLL clinical practice guidelines and implications for relapsed therapy 08/05/2025
Highlights from iwMyeloma 2025: trial updates and practical considerations 02/05/2025
Updates to the ESMO CLL clinical practice guidelines: implications for frontline treatment 25/04/2025
Highlights from EBMT 2025: preventing and managing GvHD, harnessing AI in transplant, & more 17/04/2025
Sequencing therapies in R/R NHL: immunotherapy in DLBCL, BTKis in MCL, & more! 14/04/2025
Novel CAR strategies being explored in lymphoma: allogeneic products, trispecific CARs & new manufacturing platforms 31/03/2025
Approaches to optimizing induction therapy in AML: FLT3 inhibitors, menin inhibitors, CPX-351, & more! 28/03/2025
Treating R/R mantle cell lymphoma: the role of BTK inhibitors, combination approaches being explored & overcoming resistance 24/03/2025
Addressing unmet needs in myeloma: early detection, frail/elderly patients, triple-class exposed disease, & more! 14/03/2025
CAR T-cell therapy in ALL: trial updates, novel approaches, & real-world outcomes 27/02/2025
Post-ASH amyloidosis highlights: the ANDROMEDA trial, risk stratification, value of MRD, & more! 21/02/2025
Post-ASH non-malignant highlights: updates in sickle cell disease, thalassemia, and hemophilia 14/02/2025
Post-ASH myeloma highlights: key takeaways for community physicians & trials to look out for in 2025 06/02/2025
Post-ASH AML highlights: novel approaches to frontline therapy, advances with menin inhibitors, & managing FLT3-ITD+ AML 31/01/2025
« Primera ‹ Anterior 1 2 3 4 ... 10 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA